A dual specificity promoter system combining cell cycle-regulated and tissue-specific transcriptional control

Gene Therapy

Volumn 6, Issue 7, 1999, Pages 1276-1281

  Nettelbeck, D M ^a   Jerome V ^a   Muller R ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Cell cycle regulation; Cyclin A promoter; Melanoma; Tissue specific transcription; Transcriptional targeting; Tyrosine promoter

Indexed keywords

CHIMERIC PROTEIN; CYCLIN A; DNA BINDING PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL CYCLE; CONTROLLED STUDY; GENE TARGETING; HUMAN; HUMAN CELL; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

3T3 CELLS; ANIMALS; CELL CYCLE; CYCLIN A; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; LUCIFERASES; MELANOMA; MICE; MONOPHENOL MONOOXYGENASE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 0344655604     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300943     Document Type: Article

References (33)

1. Sikora K. Gene therapy for cancer. Trends Biotech 1993; 11: 197-201.
2. Miller N, Whelan J. Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum Gene Ther 1997; 8: 803-815.
3. Rigg A, Sikora K. Genetic prodrug activation therapy. Mol Med Today 1997; 3: 359-366.
4. Müller R. Transcriptional regulation during the mammalian cell cycle. Trends Genet 1995; 11: 173-178.
5. Lucibello FC et al. Periodic cdc25C transcription is mediated by a novel cell cycle-regulated repressor element (CDE). EMBO J 1995; 14: 132-142.
6. Zwicker J et al. Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J 1995; 14: 4514-4522.
7. Liu N et al. CDF-1, a novel E2F-unrelated factor, interacts with cell cycle-regulated repressor elements in multiple promoters. Nucleic Acids Res 1997; 25: 4915-4920.
8. Zwicker J et al. Cell cycle regulation of cdc25C tanscription is mediated by the periodic repression of the glutamine-rich activators NF-Y and Sp1. Nucleic Adds Res 1995; 23: 3822-3820.
9. Dorn A et al. A multiplicity of CCAAT box-binding proteins. Cell 1987; 50: 863-872.
10. Maity SM, Golumbek PT, Karsenty G, de Crombrugghe B. Selective activation of transcription by a novel CCAAT binding factor. Science 1988; 241: 582-585.
11. van Hudisduijnen HR et al. Co-evolution from yeast to mouse: cDNA cloning of the two NF-Y (CP-1/CBF) subunits. EMBO J 1990; 9: 3119-3127.
12. Maity SN, Vuorio T, Crombrugghe B. The B subunit of a rat heteromeric CCAAT-binding transcription factor shows a striking sequence identity with the yeast Hap2 transcription factor. Proc Natl Acad Sci USA 1990; 87: 5378-5382.
13. Maity SN, Sinha S, Ruteshouse EC, de Crombrugghe B. Three different polypeptides are necessary for DNA binding of the mammalian heteromeric CCAAT binding factor. J Biol Chem 1992; 267: 16574-16580.
14. Li X-Y et al. Intron-exon organization of the NF-Y genes. Tissue-specific splicing modifies an activation domain. J Biol Chem 1992; 267: 8984-8990.
15. Mantovani R et al. Monoclonal antibodies to NF-Y define its function in MHC class II and albumin gene transcription. EMBO J 1992; 11: 3315-3322.
16. Mantovani R et al. Dominant negative analogs of NF-YA. J Biol Chem 1994; 269: 20340-20346.
17. Sinha S, Maity SN, Lu J, de Crombrugghe B. Recombinant rat CGF-C, the third subunit of CGF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and yeast HAP2 and HAP3. Proc Natl Acad Sci USA 1995; 92: 1624-1628.
18. Sinha S et al. Three classes of mutations in the A subunit of the CCAAT-binding factor CBF delineate functional domains involved in the three-step assembly of the CBF-DNA complex. Mol Cell Biol 1996; 16: 328-337.
19. Coustry F, Maity SN, de Crombrugghe B. Studies on transcription activation by the multimeric CCAAT-binding factor CBF. J Biol Chem 1995; 270: 468-475.
20. Currie RA. NF-Y is associated with the histone acetyltransferases GCN5 and P/CAF. J Biol Chem 1998; 273: 1430-1434.
21. Zwicker J et al. CDF-1 mediated repression of cell cycle genes targets a specific subset of transactivators. Nucleic Acids Res 1997; 25: 4926-4932.
22. Lech K, Anderson K, Brent R. DNA-bound fos proteins activate transcription in yeast. Cell 1988; 52: 179-184.
23. Chasman DI, Kornberg RD. GAL4 protein: purification, association with GAL80 protein and conserved domain structure. Mol Cell Biol 1990; 10: 2916-2923.
24. Webster N et al. The yeast UASG is a transcriptional enhancer in HeLa cells in the presence of the GAL4 trans-activator. Cell 1988; 52: 169-178.
25. Siders WM, Halloran PJ, Fenton RG. Transcriptional targeting of recombinant adenoviruses to human and murine melanoma cells. Cancer Res 1996; 56: 5638-5646.
26. Hwu P et al. Use of soluble recombinant TNF receptor to improve detection of TNF secretion in cultures of tumor infiltrating lymphocytes. J Immunol Meth 1992; 151: 139-147.
27. Nettelbeck DM, Jérôme V, Müller R. A new strategy for the enhancement of weak cell type-specifc promoters. Gene Therapy 1998; 5: 1656-1664.
28. Müller R, Nettelbeck D, Sedlacek HH. Chimäre Promotormodule mit rekombinanten Transkriptionsfaktoren. Patent Application 1998; DE 198 314 20.5.
29. Bean MA et al. Cell-mediated cytotoxicity for bladder carcinoma: evaluation of a workshop. Cancer Res 1975; 35: 2902-2913.
30. Sewing A et al. Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP. J Cell Sci 1993; 104: 545-555.
31. Lau QC, Brüsselbach S, Müller R. Abrogation of c-Raf expression induces apoptotis in tumor cells. Oncogene 1998; 16: 1899-1902.
32. Henglein B et al. Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc Natl Acad Sci USA 1994; 91: 5490-5494.
33. Ausubel I, Frederick M. Current Protocols in Molecular Biology. John Wiley: New York, 1991.